- MorphoSys (MOR TH) +1.2%
- PRESS RELEASE: MorphoSys’ partner Incyte announced development and commercialization agreement with InnoCare for Tafasitamab in Greater China
- BAT (BMT TH) +1%
- Henkel (HEN3 TH) -1%
- Henkel Cut to Sell at SocGen; PT 79 euros
- Freenet (FNTN TH) -1%
- Prosus (1TY TH) -3.5%
- China Tech Stocks Slump as Nation Issues Draft Competition Rules